苏州润迈德医疗科技有限公司
Pioneering the future of vascular interventional surgery with our advanced coronary angiography systems
Pioneering the future of vascular interventional surgery with our advanced coronary angiography systems
Rain Med is a pioneering startup dedicated to advancing the field of vascular interventional surgery through the development of cutting-edge coronary angiography systems. Established in 2014, the company operates within the Health Care and Robotics industries. Notably, Rain Med recently secured a significant $100.00M Series D investment on 01 December 2021 from Ping An Capital, signifying strong investor confidence in the company's innovative technological advancements. With its focus on revolutionizing vascular interventional surgical robotics, Rain Med is poised to make a significant impact in the healthcare sector and beyond.
| Funding Stage | Amount | No. Investors | Investors | Date |
|---|---|---|---|---|
| Series D | $100.00M | 1 |
|
01 Dec 2021 |
No recent news or press coverage available for 苏州润迈德医疗科技有限公司.
We care about your data, and we'd love to use cookies make your experience better.
